
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded topical solution containing podophyllum resin, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
No FDA-approved (NDA or ANDA) product containing podophyllum resin is listed. Products containing it are filed in the directory as unapproved drugs, in tincture form for use on the skin, and as homeopathic products, in oral and sublingual liquid and drop forms.
Liquid bases can be aqueous or nonaqueous, and USP <795> classifies the preparation by its water activity. Aqueous preparations carry shorter default beyond-use dates than nonaqueous ones. The date printed on the label is the one to follow.
Podophyllum resin (podophyllin) is a plant-derived cytotoxic, caustic agent that a clinician applies to warts on the skin; pharmacies may compound it on prescription.
Podophyllum resin, also called podophyllin, is the powdered mixture of resins taken from the May apple or mandrake plant (Podophyllum peltatum); an Indian source of the resin also exists. It is a cytotoxic agent that stops cell division in metaphase. Its main active component is podophyllotoxin, whose amount varies with the source of the resin. The one manufactured single-ingredient product found on DailyMed is Podocon-25 (podophyllin in benzoin tincture, Padagis), which is listed as an unapproved drug and labeled for removal of soft genital warts, applied by a physician only. Drugs@FDA lists no approved application for podophyllum resin. DailyMed also lists a combination liquid with cantharidin and salicylic acid. A prescriber might order it compounded in a strength or combination that is not manufactured. Compounded preparations are not FDA-approved and require a prescription.
The Podocon-25 label calls podophyllin a powerful caustic and severe irritant, to be applied only by a physician. If it gets in the eyes, flush with warm water and call a doctor or poison control. The label says not to use it with diabetes, steroid use or poor circulation, or on bleeding, inflamed or irritated warts, moles, birthmarks or hairy warts. The CDC reports severe whole-body toxicity when the resin was applied to large areas of broken tissue and not washed off in time. Reported reactions include tingling or numbness, nerve damage, bowel paralysis, fever, low blood counts, coma and death. Podophyllin should not be used during pregnancy (CDC); the label reports birth defects, fetal death and stillbirth and lists it as contraindicated in pregnancy and breastfeeding. Get emergency help for severe vomiting, fever or unusual drowsiness after treatment. For other side effects, talk to your prescriber or pharmacist.
Podophyllin is a cytotoxic antimitotic. Podophyllotoxin binds tubulin and arrests mitosis in metaphase, similar to colchicine, and its caustic effect is delayed, with cell death and tissue erosion following mitotic arrest (INCHEM). The resin contains at least 16 active compounds; the main lignans are podophyllotoxin, alpha-peltatin and beta-peltatin. The Podocon label states that American resin normally contains one fourth the podophyllotoxin of Indian resin. Topical podophyllin is absorbed systemically, especially through non-intact skin, and crosses the placenta; symptoms may be delayed 2 to 24 hours, and peripheral neuropathy can appear about 2 weeks after application and persist for 9 months or longer (INCHEM). Labeled indication (Podocon-25, unapproved drug): removal of soft genital warts (condylomata acuminata), physician-applied. The CDC 2021 STI Treatment Guidelines no longer list podophyllin resin as a recommended regimen; it might be considered for provider-administered treatment under strict adherence, with limits on volume, area treated and contact time and a thorough wash-off. CDC notes that resin preparations differ in active components and contaminants and that their shelf life and stability are unknown. Application technique is per prescriber. Monitor for local reactions and for neurologic, hematologic and gastrointestinal signs of systemic toxicity.
Wash your hands. Apply the amount on your label to clean, dry skin using the applicator provided or a cotton swab. Let it dry before covering. Use an accurate measuring device if your label gives a volume. Keep it away from the eyes and avoid open flame if the solution contains alcohol. Wash your hands afterward.
Topical solutions are aqueous or alcohol based. Under USP <795>, a preserved aqueous solution usually carries a beyond-use date of up to 35 days; an unpreserved one 14 days refrigerated; a nonaqueous solution may carry up to 180 days. Keep the bottle tightly closed at room temperature, away from heat and flame, out of reach of children, and discard after the beyond-use date on your label.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)